Physician profile
John E Maanum
NPI 1356303721
$3,910.48
in general payments reported to CMS, 2019-2025
17 companies · $792 in 2025
The $792 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $262 · 2021: $464 · 2022: $426 · 2023: $625 · 2024: $891 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980 · Entertainment: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.46 |
| Entertainment | $327.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,075.57 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Coopervision INC. | $864.51 | 2019-2025 | Myday Contact Lens, Onefit Contact Lens, Misight Contact Lens |
| Optos, INC. | $473.89 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $410.15 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $243.25 | 2022-2025 | Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.52 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $135.73 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Astellas Pharma US INC | $124.90 | 2024 | Izervay |
| Glaukos Corporation | $122.76 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $99.93 | 2019 | |
| Lkc Technologies, INC. | $61.08 | 2024 | |
| Amgen INC. | $30.08 | 2024 | Tepezza |
| Biotissue Holdings INC. | $27.03 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $26.78 | 2024 | Xdemvy |
| Abbvie INC. | $19.86 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $18.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Maanum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.